Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Raphael Pharmaceutical Inc. (ESYE)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   10-K/A10-K/A10-K
Revenues  1.50.80.1
            Revenue growth  95.7%649.5% 
Cost of goods sold  0.00.00.0
Gross profit  1.50.80.1
            Gross margin  100.0%100.0%100.0%
Selling, general and administrative   [+]2.10.90.2
Research and development  1.20.80.5
Other operating expenses  1.40.70.1
EBIT   [+]-3.2-1.6-0.7
            EBIT margin  -214.8%-201.3%-685.4%
Non-recurring items  0.10.1 
Other income (expense), net  6.73.31.4
Pre-tax income  3.41.60.7
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  3.41.60.7
            Net margin  222.2%210.5%697.1%
   
Basic EPS   [+]$0.23$0.15$0.08
Diluted EPS   [+]$0.23$0.15$0.08
   
Shares outstanding (basic)   [+]14.311.29.5
Shares outstanding (diluted)   [+]14.311.29.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy